Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Product revenue $ 207 $ 97
Costs of revenue 166 79
Gross profit 41 18
Operating expenses:    
Research and development 994 718
General and administrative 764 971
Sales and marketing 137 59
Total operating expenses 1,895 1,748
Loss from operations (1,854) (1,730)
Other income (expenses):    
Interest expense (1)
Interest income 104 122
Change in fair value of derivative liabilities 4,166 (21)
Offering costs associated with warrant derivatives (1,246)
Total other income, net 3,023 101
Net income (loss) before income taxes 1,169 (1,629)
Provision for income taxes
Net income (loss) 1,169 (1,629)
Deemed dividend related to the beneficial conversion feature and accretion of a discount on preferred stock (9,284)
Net loss attributable to common stockholders $ (8,115) $ (1,629)
Net loss per share - basic and diluted    
Basic - net income (loss) $ 0.19 $ (2.24)
Basic - deemed dividend and accretion of a discount on conversion of preferred stock (1.54)
Basic - attributable to common stockholders (1.35) (2.24)
Diluted - loss (0.37) (2.24)
Diluted - deemed dividend and accretion of a discount on conversion of preferred stock (1.16)
Diluted - attributable to common stockholders $ (1.53) $ (2.24)
Weighted average common shares outstanding:    
Basic 6,020,889 726,455
Diluted 8,035,392 726,455